Effect of BMY-28100, a new cephalosporin, on Staphylococcus aureus nasal carriage.

R L Atmar, M L Allen, J Freiman, C Kiefe, S Ehrman, S B Greenberg
{"title":"Effect of BMY-28100, a new cephalosporin, on Staphylococcus aureus nasal carriage.","authors":"R L Atmar, M L Allen, J Freiman, C Kiefe, S Ehrman, S B Greenberg","doi":"10.1007/BF02013070","DOIUrl":null,"url":null,"abstract":"<p><p>In order to examine the in vivo activity of BMY-28100, serial quantitative nasal cultures were taken from 52 nasal carriers of Staphylococcus aureus following administration of the antimicrobial. Nasal carriage rates and mean log titers decreased significantly during (days 2-4 and 5-8) and following (days 1-2 and 6-7) treatment. No change in antibiotic sensitivities was noted in follow-up isolates, and the MIC90 remained at 2mcg/ml. BMY-28100 demonstrated good in vivo activity against Staphylococcus aureus.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1987-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02013070","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF02013070","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

In order to examine the in vivo activity of BMY-28100, serial quantitative nasal cultures were taken from 52 nasal carriers of Staphylococcus aureus following administration of the antimicrobial. Nasal carriage rates and mean log titers decreased significantly during (days 2-4 and 5-8) and following (days 1-2 and 6-7) treatment. No change in antibiotic sensitivities was noted in follow-up isolates, and the MIC90 remained at 2mcg/ml. BMY-28100 demonstrated good in vivo activity against Staphylococcus aureus.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新型头孢菌素 BMY-28100 对金黄色葡萄球菌鼻腔携带的影响
为了研究 BMY-28100 的体内活性,在服用该抗菌剂后,对 52 名金黄色葡萄球菌鼻腔携带者进行了连续定量鼻腔培养。在治疗期间(第 2-4 天和第 5-8 天)和治疗后(第 1-2 天和第 6-7 天),鼻腔携带率和平均对数滴度均显著下降。后续分离物对抗生素的敏感性没有变化,MIC90 仍为 2 毫克/毫升。BMY-28100 对金黄色葡萄球菌具有良好的体内活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Modulation of human neutrophil and monocyte oxidative burst by Legionella pneumophila sonic extract. Evaluation of three methods for typing herpes simplex virus. Comparative activity of LY146032 against anaerobic cocci. Comparative in vitro activity of the new peptolide antibiotic LY146032 against staphylococci. LY146032 treatment of Clostridium difficile colitis in hamsters.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1